DE3577579D1 - Verwendung eines zelloberflaechenprotein gewonnen aus staph. aureus. - Google Patents

Verwendung eines zelloberflaechenprotein gewonnen aus staph. aureus.

Info

Publication number
DE3577579D1
DE3577579D1 DE8585850190T DE3577579T DE3577579D1 DE 3577579 D1 DE3577579 D1 DE 3577579D1 DE 8585850190 T DE8585850190 T DE 8585850190T DE 3577579 T DE3577579 T DE 3577579T DE 3577579 D1 DE3577579 D1 DE 3577579D1
Authority
DE
Germany
Prior art keywords
cell surface
surface protein
fibrinogen
collagen
fibronectin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8585850190T
Other languages
English (en)
Inventor
Magnus Hoeoek
Kjell Martin Lindberg
Torkel Mikael Wadstroem
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alfa Laval Agri International AB
Original Assignee
Alfa Laval Agri International AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alfa Laval Agri International AB filed Critical Alfa Laval Agri International AB
Application granted granted Critical
Publication of DE3577579D1 publication Critical patent/DE3577579D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Materials For Medical Uses (AREA)
DE8585850190T 1984-05-30 1985-05-30 Verwendung eines zelloberflaechenprotein gewonnen aus staph. aureus. Expired - Lifetime DE3577579D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8402938A SE454403B (sv) 1984-05-30 1984-05-30 Anvendning av ett cellyteprotein med fibronektin-, fibrinogen-, kollagen-, och/eller lamininbindande egenskaper vid framstellning av sarbehandlingsmedel

Publications (1)

Publication Number Publication Date
DE3577579D1 true DE3577579D1 (de) 1990-06-13

Family

ID=20356083

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8585850190T Expired - Lifetime DE3577579D1 (de) 1984-05-30 1985-05-30 Verwendung eines zelloberflaechenprotein gewonnen aus staph. aureus.

Country Status (13)

Country Link
EP (1) EP0163623B1 (de)
JP (1) JPH0747541B2 (de)
AT (1) ATE52543T1 (de)
AU (1) AU600886B2 (de)
CA (1) CA1340401C (de)
DE (1) DE3577579D1 (de)
ES (1) ES8900019A1 (de)
FI (1) FI84431C (de)
IE (1) IE59203B1 (de)
NO (1) NO164992C (de)
NZ (1) NZ212244A (de)
SE (1) SE454403B (de)
WO (1) WO1985005553A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8702272L (sv) * 1987-06-01 1988-12-02 Alfa Laval Agri Int Fibronektinbindande protein samt dess framstaellning
SE8801723D0 (sv) * 1988-05-06 1988-05-06 Staffan Normark Fibronectin binding protein as well as its preparation
SE8801894D0 (sv) * 1988-05-20 1988-05-20 Alfa Laval Agri Int Fibronektinbindande protein
SE8901687D0 (sv) * 1989-05-11 1989-05-11 Alfa Laval Agri Int Fibronectin binding protein as well as its preparation
US5440014A (en) * 1990-08-10 1995-08-08 H+E,Uml/Oo/ K; Magnus Fibronectin binding peptide
SE9003374D0 (sv) * 1990-10-22 1990-10-22 Alfa Laval Agri Int A collagen binding protein as well as its preparation
US5980908A (en) * 1991-12-05 1999-11-09 Alfa Laval Ab Bacterial cell surface protein with fibronectin, fibrinogen, collagen and laminin binding ability, process for the manufacture of the protein and prophylactic treatment
EP0621875B1 (de) * 1992-09-21 2002-03-27 Alfa-Laval Agri International Ab Fibrinogen-bildungsprotein
JPH0840932A (ja) * 1994-07-29 1996-02-13 Kitasato Inst:The スタフイロコッカス属菌感染症の予防ワクチン及び治療用抗体並びにそれの製造法
GB9415902D0 (en) * 1994-08-05 1994-09-28 Smithkline Beecham Plc Method of treatment
US6685943B1 (en) 1997-01-21 2004-02-03 The Texas A&M University System Fibronectin binding protein compositions and methods of use
US6703025B1 (en) 1998-08-31 2004-03-09 Inhibitex, Inc. Multicomponent vaccines
WO2000012131A1 (en) * 1998-08-31 2000-03-09 Inhibitex, Inc. Multicomponent vaccines
US6692739B1 (en) * 1998-08-31 2004-02-17 Inhibitex, Inc. Staphylococcal immunotherapeutics via donor selection and donor stimulation
US6908994B1 (en) 1999-05-10 2005-06-21 The Texas A&M University System Collagen-binding proteins from enterococcal bacteria
CA2517439C (en) 2003-03-07 2013-07-23 Wyeth Holdings Corporation Polysaccharide - staphylococcal surface adhesin carrier protein conjugates for immunization against nosocomial infections
EP2548884B1 (de) 2005-08-10 2017-08-02 Arne Forsgren AB Wechselwirkung von Moraxella Catarrhalis mit Epithelzellen, extrazellulären Matrixproteinen und dem Komplementsystem
JP5395264B2 (ja) 2009-06-22 2014-01-22 ワイス・エルエルシー 黄色ブドウ球菌（ｓｔａｐｈｙｌｏｃｏｃｃｕｓａｕｒｅｕｓ）抗原の免疫原性組成物
GB0913680D0 (en) 2009-08-05 2009-09-16 Glaxosmithkline Biolog Sa Immunogenic composition
TW201302779A (zh) 2011-04-13 2013-01-16 Glaxosmithkline Biolog Sa 融合蛋白質及組合疫苗

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU561067B2 (en) * 1982-03-22 1987-04-30 Biocarb Ab Anti-bacterial composition containing an oligosaccharide

Also Published As

Publication number Publication date
JPS61502334A (ja) 1986-10-16
ES8900019A1 (es) 1988-11-01
EP0163623A2 (de) 1985-12-04
AU600886B2 (en) 1990-08-30
SE8402938L (sv) 1985-12-01
NZ212244A (en) 1989-03-29
NO164992C (no) 1990-12-05
FI84431C (fi) 1991-12-10
SE454403B (sv) 1988-05-02
IE59203B1 (en) 1994-01-26
JPH0747541B2 (ja) 1995-05-24
FI860417A0 (fi) 1986-01-29
SE8402938D0 (sv) 1984-05-30
WO1985005553A1 (en) 1985-12-19
ATE52543T1 (de) 1990-05-15
FI860417A (fi) 1986-01-29
ES543635A0 (es) 1988-11-01
NO164992B (no) 1990-08-27
EP0163623B1 (de) 1990-05-09
CA1340401C (en) 1999-02-23
FI84431B (fi) 1991-08-30
NO860321L (no) 1986-01-29
EP0163623A3 (en) 1987-02-25
IE851337L (en) 1985-11-30

Similar Documents

Publication Publication Date Title
DE3577579D1 (de) Verwendung eines zelloberflaechenprotein gewonnen aus staph. aureus.
DE68925002D1 (de) Verfahren zur Herstellung von optisch-aktiven alpha-substituierten organischen Säuren und Mikroorganismen und Enzyme, die dafür verwendet werden.
DE68913817D1 (de) Verfahren zur Herstellung einer dem Kefir ähnlichen Sauermilch.
DE3789428D1 (de) Mikroorganismen, fähig zur Laktoseassimilation.
AU588793B2 (en) Method of expressing alpha-1-antitrypsin in bacteria
BR8702649A (pt) Composicao biocida,processo para inibicao do crescimento de microorganismos,meio,couro ou madeira,composto e complexo ferrico
DE59309972D1 (de) Pseudomonas aeruginosa und seine Verwendung zur Herstellung von L-Rhamnose
ATE30049T1 (de) Verfahren zur herstellung von d-milchsaeure unter verwendung von lactobacillus bulgaricus dsm 2129.
DE3778852D1 (de) Arzneimittel enthaltend das gewebeprotein pp4, verfahren zur herstellung von pp4 und zu seiner pasteurisierung sowie die verwendung von pp4.
DK0418945T3 (da) Forgreningsenzym og dets anvendelse
ATE43500T1 (de) Herstellung von antikoerpern.
DE3786788D1 (de) Gasdurchlaessige wasserabweisende membran und verfahren zur herstellung.
DE3884735D1 (de) Material für die fischerei, ausgezeichnet zur verhinderung des anklebens von mikroorganismen,und verfahreen zu dessen herstellung.
BR9007636A (pt) Bio-herbicida combinando agentes quimicos e patogenos de plantas bacterianos
SE8104840L (sv) Framstellning av endoproteinas
ATE376586T1 (de) Ppgpp-synthetase und expressionssysteme zur verbesserten herstellung von proteinen
DE58907274D1 (de) VERFAHREN ZUR STEIGERUNG VON ENZYM-AKTIVITÄTEN UND DER SYNTHESELEISTUNG VON MIKROORGANISMEN UND HöHEREN PFLANZEN.
FR2429765A1 (fr) Procede et agent d'adsorption pour isoler des enzymes et pour les preparer a l'etat pur
ATE95188T1 (de) Zellulaere amphipatische proteine in aggregierten formen und verfahren zur herstellung und reinigung diese proteine.
DE3884922D1 (de) Verfahren zur Herstellung von thermostabilen alpha-Amylasen durch Kultivierung von überproduzierenden Mikroorganismen.
AU1786300A (en) Gram-positive bacteria deprived of htra proteasic activity and their uses
DK143984D0 (da) Nitrogenkilde til organismer
DE3885380D1 (de) Verfahren zur Herstellung von modifiziertem, ferromagnetischem Chromdioxid.
ATE23189T1 (de) Verfahren zur herstellung von sphaerischen zellaggregaten von mikroorganismen.
DE69015002D1 (de) Verfahren zur Herstellung von Milchprodukten.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition